| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. ![]() |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| ALCAR | acetyl-L-carnitine |
| CPT | carnitine palmityl transferase; carotid pulse tracing; chest physiotherapy; child protection team; c... |
| MCD | magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ... |
| SCD | scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu... |
| ALC | Acetyl-L-Carnitine |
|---|---|
| ALCAR | Acetyl-L-Carnitine |
| CPT | Carnitine Palmitoyl Transferase |
| CPTI | Carnitine Palmitoyltransferase I |
| CAT | Carnitine acetyltransferase |
naso-oral
| carnitine | <biochemistry> _ Hydroxy _ trimethyl aminobutyric acid. Compound that transports long chain fatty acids across the inner mitochondrial membrane in the form of acyl carnitine. Sometimes referred to as Vitamin Bt or Vitamin B7. (18 Nov 1997) |
|---|---|
| carnitine acyltransferases | <enzyme> Acyltransferases in the inner mitochondrial membrane that catalyze the reversible transfer of acyl groups from acyl-CoA to l-carnitine and thereby mediate the transport of activated fatty acids through that membrane. Registry number: EC 2.3.1.- (12 Dec 1998) |
| carnitine amidase | <enzyme> Hydrolyzes l-carnitine amide steroselectively Registry number: EC 3.5.1.- (26 Jun 1999) |
| carnitine coenzyme A ligase | <enzyme> Caic protein isolated from e. Coli Registry number: EC 6.2.1.- Synonym: carnitine CoA ligase, crotonobetaine CoA ligase, caic gene product (26 Jun 1999) |
| carnitine dehydratase | <enzyme> From E coli; catalyses the reversible dehydration of (l)-carnitine forming crotonobetaine Registry number: EC 4.2.1.- Synonym: caib protein, caib gene product (26 Jun 1999) |
| carnitine o-acetyltransferase | <enzyme> An enzyme that catalyses the formation of o-acetylcarnitine from acetyl-CoA plus carnitine. Chemical name: Acetyl-CoA:carnitine O-acetyltransferase Registry number: EC 2.3.1.7 (12 Dec 1998) |
| carnitine o-palmitoyltransferase | <enzyme> An enzyme that catalyses reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. Chemical name: Palmitoyl-CoA:L-carnitine O-palmitoyltransferase Registry number: EC 2.3.1.21 (12 Dec 1998) |
| carnitine palmitoyltransferase | <enzyme> An enzyme that reversibly forms acylcarnitines and coenzyme A from carnitine and acylcoenzyme A (often, palmitoyl-CoA); important in fatty acid oxidation. Deficiency of isozyme I results in ketogenesis with hypoglycaemia; deficiency of isozyme II affects primarily skeletal muscle. (05 Mar 2000) |
| carnitine racemase | <enzyme> Homologous to enoyl hydratases and isomerases; converts d(+)-carnitine to l(-)-carnitine; isolated from e. Coli Registry number: EC 5.1.- Synonym: caid gene product (26 Jun 1999) |
| l-carnitine | <amino acid> Is a dipeptide - an amino acid made from two other aminos, methionine and lysine. It can be synthesised in the liver if sufficient amounts of lysine, B1, B6 and iron are available. Muscle and organ meat, fish and milk products are the best sources of carnitine in the diet. Carnitine has been shown to have a major role in the metabolism of fat and in the reduction of triglycerides by increasing fat utilisation. It transfers fatty acids across the membranes of the mitochondria where they can be utilised as sources of energy. It also increases the rate at which the liver uses fats. By preventing fatty build-up, this amino acid aids in weight loss and decreases the risk of heart disease. Carnitine has been shown to be deficient in hearts of patients who have died of acute myocardial infections. Muscular dystrophy and myotonic dystrophy have been shown to lead to carnitine loss in the urine and therefore higher requirements for it. Carnitine is stored primarily in the skeletal muscles and heart, where it is needed to transform fatty acids into energy for muscular activity. It is also concentrated in sperm and the brain. Many athletes have noted increased endurance and muscle building with carnitine supplementation. Deficiencies may increase symptoms of fatigue, angina, muscle weakness or confusion. A low level of Vitamin C will also result in apparent Carnitine deficiency. It is contraindicated for people with liver or kidney disease or diabetes It has proven helpful in improving lipid metabolism and reducing elevated total lipids, cholesterol and triglycerides in people with cardiac problems and diabetes, but should only be taken with medical supervision in these conditions. (25 Jun 1999) |
| administration, oral | The giving of drugs, chemicals, or other substances by mouth. (12 Dec 1998) |
| cancer, oral | Cancer of the mouth area. A sore in the mouth that does not heal can be a warning sign of oral cancer. A biopsy is the only to know whether as abnormal area in the oral cavity is cancer. Oral cancer is caused by tobacco (smoking and chewing) and alcohol use. Surgery to remove the tumour in the mouth is the usual treatment for patients with oral cancer. (12 Dec 1998) |
| candidiasis, oral | Infection of the mucous membranes of the mouth by a fungus of the genus candida. (12 Dec 1998) |
| canine oral papilloma | Warts affecting mucous membranes of young dogs; caused by a papillomavirus. (05 Mar 2000) |
| magnesia and alumina oral suspension | A mixture of magnesium hydroxide and variable amounts of aluminum oxide; used as an antacid. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|